Skip to main content

GMP-like Manufacturability Study of On-dose Anticounterfeiting Technology

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Sep 11, 2012
Award amount: 
$247,270
Organization name: 
CertiRx Corporation
Principal Investigator: 
Mercolino, Thomas J
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

PUBLIC INFORMATION SUMMARY
The increasing prevalence of counterfeit prescription products in the United States is a rising cause of concern. CertiRx Corporation is developing product authentication technology covered under US Pat. No. 7,874,489 and other pending applications, which will allow ready identification of counterfeits and more effective tracking of lost, damaged, stolen, or diverted goods.
During this project we intend to demonstrate a commercially viable manufacturing method for solid oral dosage formulations containing CertiRx authentication technology. In addition we will manufacture encoded dosage prototypes that will be used in the quantitative performance assessment of the CertiRx proprietary hardware and software.

Fiscal year: 
2013